ADC Therapeutics SA

ADCT

CH0499880968

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 14:05:55 2024-07-08 EDT			5-day change	1st Jan Change
3.18 ^USD	-2.45%		-15.35%	+87.65%

12:00am	Certain Options of ADC Therapeutics SA are subject to a Lock-Up Agreement Ending on 8-JUL-2024.	CI
12:00am	Certain Common Shares of ADC Therapeutics SA are subject to a Lock-Up Agreement Ending on 8-JUL-2024.	CI

ADC Therapeutics SA(NYSE:ADCT) added to Russell Small Cap Completeness Index

July 30, 2024

Latest news about ADC Therapeutics SA

Certain Options of ADC Therapeutics SA are subject to a Lock-Up Agreement Ending on 8-JUL-2024.	2024-07-07	CI
Certain Common Shares of ADC Therapeutics SA are subject to a Lock-Up Agreement Ending on 8-JUL-2024.	2024-07-07	CI
Certain Restricted Stock Units of ADC Therapeutics SA are subject to a Lock-Up Agreement Ending on 8-JUL-2024.	2024-07-07	CI
Certain Warrants of ADC Therapeutics SA are subject to a Lock-Up Agreement Ending on 8-JUL-2024.	2024-07-07	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell Small Cap Comp Value Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell Small Cap Completeness Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell Microcap Growth Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 3000 Value Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 2000 Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 3000E Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell Microcap Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 2500 Value Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 3000 Growth Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 2000 Value Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 3000E Growth Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 2000 Growth Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 2000 Dynamic Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell Microcap Value Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 2500 Growth Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell Small Cap Comp Growth Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 2500 Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 3000 Index	06-30	CI
ADC Therapeutics SA(NYSE:ADCT) added to Russell 3000E Value Index	06-30	CI
ADC Therapeutics to Join Russell 3000 Index	06-27	MT
Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating	05-30	MT

ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkinâs lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Sector

Biotechnology & Medical Research

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for ADC Therapeutics SA

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.26 USD

Average target price

10 USD

Spread / Average Target

+206.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
ADC THERAPEUTICS SA	+87.65%	314M
VERTEX PHARMACEUTICALS INCORPORATED	+18.39%	122B
REGENERON PHARMACEUTICALS, INC.	+19.45%	112B
BIONTECH SE	-23.97%	19.33B
GENMAB A/S	-18.45%	16.17B
BEIGENE, LTD.	-18.78%	15.6B
WUXI APPTEC CO., LTD.	-49.33%	14.65B
SAREPTA THERAPEUTICS, INC.	+57.55%	14.34B
NEUROCRINE BIOSCIENCES, INC.	+7.04%	14B
INSMED INCORPORATED	+126.33%	11.29B

Bio Therapeutic Drugs